EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Bioartificial Kidney: History, Present, and Future

Ziqi Zhang, Zehao Zhang, Tingting Zhang, Yaqi Wang, Yu Zhao, Yixue Zhang, Xiaolan Chen, Xiayin Li, Ming Bai

Blood Purification · 2026-11-06

DOI: 10.1159/bpu/abpag030 ↗
AbstractBibliografische Angaben

Abstract

Abstract End-stage kidney disease (ESKD) demands novel treatments capable of simulating the physiological functions of native kidneys. The bioartificial kidney (BAK), combining a glomerular biomimetic filter and a cell-based bioreactor to restore tubular functions, is a promising therapeutic option that is still under preclinical development. This article reviews the technological evolution of BAK, summarizes the latest progress in membrane materials, cell resources and bioreactor construction, and elaborates on key supporting technologies such as kidney-on-a-chip systems, decellularization-recellularization and device miniaturization. Although considerable achievements have been made, critical hurdles including poor biocompatibility, unstable cell activity, immune isolation defects and insufficient vascularization still hinder its clinical application. Future development depends on interdisciplinary collaboration between precision medicine and smart bioengineering, to ultimately promote the clinical translation of BAK for ESKD treatment.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →